Diagnostics · Webhook
Documents where the remote endpoint responded with an error status.
| Document | Seed URL | Status | Error | Payload |
|---|---|---|---|---|
|
CII Health Summit 2023 Highlights and Outcomes
Score: 80 · Relevant: Yes
https://www.cii.in/PressreleasesDetail.aspx?id=79274&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:22:45.812352
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CII Health Summit 2023 Highlights and Outcomes",
"is_relevant": true,
"local_file_path": "",
"release_date": "2023-11-25",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:58:55.889000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This document is a media release from the CII National Healthcare Council detailing the key highlights and outcomes of the 20th edition of the CII Health Summit 2023, held in New Delhi on November 25, 2023. The summit, themed \"R.A.I.S.E. HEALTHCARE - Responsible, Accessible, Innovative, Sustainable, Equitable,\" focused on the critical challenges of healthcare delivery in India. It involved discussions with policymakers and industry experts and saw the release of a report on the future of India\u0027s healthcare sector.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=79274\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
CII Global MedTech Summit 2024 Highlights
Score: 60 · Relevant: No
https://www.cii.in/PressreleasesDetail.aspx?id=79922&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:22:45.636037
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CII Global MedTech Summit 2024 Highlights",
"is_relevant": false,
"local_file_path": "",
"release_date": "2024-08-06",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:58:56.804000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This document provides a detailed account of the 16th CII Global MedTech Summit 2024, organized by the Confederation of Indian Industry, focusing on the evolving MedTech industry in India. It features discussions from industry leaders and government officials emphasizing Public-Private Partnerships, regulatory reforms, and India\u0027s potential as a global hub for medical devices. Key topics include innovation, quality standards, market strategies, and policy frameworks necessary for the sector\u0027s growth.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=79922\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
7th CII AYUSH Conclave Overview and Sector Growth
Score: 60 · Relevant: No
https://www.cii.in/PressreleasesDetail.aspx?id=79571&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:22:45.459323
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "7th CII AYUSH Conclave Overview and Sector Growth",
"is_relevant": false,
"local_file_path": "",
"release_date": "2024-03-22",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:58:57.063000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This document details the 7th CII AYUSH Conclave, highlighting the significant growth of the AYUSH sector in India to $24 billion over eight years. It elaborates on initiatives by the Ministry of AYUSH to promote the sector, such as collaborations for research and development with various institutions, efforts for global market integration, and quality enhancement strategies. The document emphasizes the need for continued collaboration between the government and industry to achieve further progress in the AYUSH sector.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=79571\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
One Health Strategies from 4th Public Health Summit 2023
Score: 60 · Relevant: No
https://www.cii.in/PressreleasesDetail.aspx?id=79208&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:22:45.268181
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "One Health Strategies from 4th Public Health Summit 2023",
"is_relevant": false,
"local_file_path": "",
"release_date": "2023-10-26",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:58:58.788000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This document is a media release from the Confederation of Indian Industry (CII), detailing the 4th Public Health Summit 2023 held on October 26, 2023. The summit focused on the \u0027One Health\u0027 approach, emphasizing the interconnectedness of human, animal, and environmental health, and was attended by eminent figures such as Dr V K Paul from NITI Ayog. It outlined the strategic framework of \u0027One Health\u0027 through prevention, pandemic preparedness, integrated surveillance, and joint responses.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=79208\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
IMA Election Report 2024-2026 Results and Process
Score: 40 · Relevant: No
https://ima-india.org/ima/pdfdata/Report-of-IMA-Elections-for-the-years-2024-2025-and-2025-2026.pdf
|
Indian Medical Association
2025-12-30T15:22:45.066458
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "IMA Election Report 2024-2026 Results and Process",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e2142b1e3c054ddb3113/Report-of-IMA-Elections-for-the-years-2024-2025-and-2025-2026.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T15:00:13.528000Z",
"seed_url": "https://www.ima-india.org/ima/important-news-listing.php",
"summary": "This document is a detailed report on the Indian Medical Association\u0027s (IMA) election process and results for the years 2024-2025 and 2025-2026. It covers the election notification, nomination process, validation of nominations, withdrawal and finalization of successful candidates, and the results declaration, which listed 50 candidates elected unopposed. The documentation is signed by Dr. Mahesh B. Patel, Chief Election Commissioner, and other members of the IMA Election Commission.",
"url": "https://ima-india.org/ima/pdfdata/Report-of-IMA-Elections-for-the-years-2024-2025-and-2025-2026.pdf"
}
|
|
IMA Donation Report for Kerala Flood Relief
Score: 40 · Relevant: No
https://ima-india.org/ima/pdfdata/Kerala-Flood-Donation-received-by-IMA-Website-as-on-24-08-2018.pdf
|
Indian Medical Association
2025-12-30T15:22:44.867403
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "IMA Donation Report for Kerala Flood Relief",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e2142b1e3c054ddb3115/Kerala-Flood-Donation-received-by-IMA-Website-as-on-24-08-2018.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T15:00:15.119000Z",
"seed_url": "https://www.ima-india.org/ima/important-news-listing.php",
"summary": "This document is a detailed report from the Indian Medical Association (IMA), listing donations received from various members and branches for the Kerala Flood Relief as of August 24, 2018. It includes names, donation amounts, and transaction details. The report is primarily an internal document summarizing contributions for organizational accounting purposes.",
"url": "https://ima-india.org/ima/pdfdata/Kerala-Flood-Donation-received-by-IMA-Website-as-on-24-08-2018.pdf"
}
|
|
Cloudflare Timeout Issue for IMA Website
Score: 0 · Relevant: No
https://www.ima-india.org/ima/important-news.php?id=288
|
Indian Medical Association
2025-12-30T15:22:44.671314
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Cloudflare Timeout Issue for IMA Website",
"is_relevant": false,
"local_file_path": "",
"release_date": "2025-12-30",
"relevancy_score": 0,
"scraped_at": "2025-12-30T15:00:33.732000Z",
"seed_url": "https://www.ima-india.org/ima/important-news-listing.php",
"summary": "This document is a troubleshooting error message from Cloudflare indicating a timeout issue between their network and a web server for the website www.ima-india.org. It provides steps on what website visitors or owners could do in response to the error. No specific content from the Indian Medical Association is included in the document.",
"url": "https://www.ima-india.org/ima/important-news.php?id=288"
}
|
|
Indian Public Health Standards Volume Four
Score: 30 · Relevant: No
https://indiannursingcouncil.org/uploads/files/SubCenters_2022.pdf
|
Indian Nursing Association
2025-12-30T15:14:59.385988
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Indian Public Health Standards Volume Four",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb310e/SubCenters_2022.pdf",
"release_date": "2025-12-30",
"relevancy_score": 30,
"scraped_at": "2025-12-30T14:58:45.390000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is the fourth volume of the \u0027Indian Public Health Standards\u0027 related to health and wellness centers and sub-health centers. It is issued by the Ministry of Health \u0026 Family Welfare. The document likely outlines standards and guidelines for the functioning of sub-health centers within India.",
"url": "https://indiannursingcouncil.org/uploads/files/SubCenters_2022.pdf"
}
|
|
State of the World Midwifery Report 2021
Score: 60 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/163300043497475222161559bf2516cb.pdf
|
Indian Nursing Association
2025-12-30T15:14:58.209170
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "State of the World Midwifery Report 2021",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb310d/163300043497475222161559bf2516cb.pdf",
"release_date": "2025-12-30",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:58:45.409000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document, led by the United Nations Population Fund (UNFPA) in partnership with WHO and the International Confederation of Midwives, focuses on the state of midwifery around the world in 2021. It highlights efforts to build a health workforce capable of meeting the needs of women, newborns, and adolescents globally. The report features contributions from a variety of international health organizations and experts, emphasizing global midwifery and maternal health statistics and strategies.",
"url": "https://indiannursingcouncil.org/uploads/pdf/163300043497475222161559bf2516cb.pdf"
}
|
|
Indian Public Health Standards for Hospitals 2022
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/files/Sub_district_Sub-divisionalHospital_2022.pdf
|
Indian Nursing Association
2025-12-30T15:14:57.051398
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Indian Public Health Standards for Hospitals 2022",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1eb0d03278c6ddb3111/Sub_district_Sub-divisionalHospital_2022.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:58:45.885000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document, issued by the Ministry of Health \u0026 Family Welfare, details the Indian Public Health Standards for sub-district and district hospitals for the year 2022. It likely covers guidelines, standards, and practices within Indian health institutions. This is part of a larger volume focused on public health standards and institutional guidelines.",
"url": "https://indiannursingcouncil.org/uploads/files/Sub_district_Sub-divisionalHospital_2022.pdf"
}
|
|
Indian Public Health Standards for Primary Health Centres 2022
Score: 39 · Relevant: No
https://indiannursingcouncil.org/uploads/files/PrimayHealthCentre_2022.pdf
|
Indian Nursing Association
2025-12-30T15:14:53.376877
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Indian Public Health Standards for Primary Health Centres 2022",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1eb0d03278c6ddb310f/PrimayHealthCentre_2022.pdf",
"release_date": "2025-12-30",
"relevancy_score": 39,
"scraped_at": "2025-12-30T14:58:46.195000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document outlines standards for Health and Wellness Centres and Primary Health Centres in India, as part of the Indian Public Health Standards. Published by the Ministry of Health \u0026 Family Welfare, this is Volume III of their series for 2022, providing detailed guidelines and protocols to improve healthcare delivery at the primary level.",
"url": "https://indiannursingcouncil.org/uploads/files/PrimayHealthCentre_2022.pdf"
}
|
|
CII Public Health Summit 2025 Report: Innovations and Partnerships
Score: 80 · Relevant: Yes
https://www.cii.in/PressreleasesDetail.aspx?id=81388&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:14:51.690943
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CII Public Health Summit 2025 Report: Innovations and Partnerships",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ec57d4251bebdb30f8/2023_PressRelease.pdf",
"release_date": "2025-09-17",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:58:48.612000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "The document is a media release from the Confederation of Indian Industry (CII) about the 6th CII Public Health Summit in 2025. It discusses the summit\u0027s theme on prioritizing people, partnerships, and innovations in public health. The release highlights discussions and initiatives proposed in the summit to improve healthcare delivery in India, especially in maternal and child health, and includes perspectives from prominent leaders and stakeholders.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=81388\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
India's Healthcare Innovations: AI and Global Collaborations
Score: 80 · Relevant: Yes
https://www.cii.in/PressreleasesDetail.aspx?id=81511&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:14:51.110917
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "India\u0027s Healthcare Innovations: AI and Global Collaborations",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ec57d4251bebdb30f7/Economic_Outlook_Report_Oct_2023.pdf",
"release_date": "2025-11-11",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:58:49.134000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This document is a media release from the CII Healthcare Council discussing India\u0027s advancements in healthcare, emphasizing the role of Artificial Intelligence in transforming healthcare delivery. It highlights the improvements in healthcare indicators in India, mentions collaborations with Japan, and introduces a tripartite MOU focused on healthcare technology and policy research. The release was issued on November 11, 2025.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=81511\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
WHO Affirms Partnership with India for Health Innovations
Score: 60 · Relevant: No
https://www.cii.in/PressreleasesDetail.aspx?id=81536&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:14:50.463867
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "WHO Affirms Partnership with India for Health Innovations",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ec57d4251bebdb30f6/PressRelease_CII22Summit2023.pdf",
"release_date": "2025-11-14",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:58:50.382000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "The document is a media release from the CII Partnership Summit where WHO Director General Dr. Tedros Adhanom Ghebreyesus emphasized India\u0027s crucial role in the global pandemic response and the significance of the Ayushman Bharat scheme. It also details discussions around India\u0027s advancement in precision medicine and AI, highlighting various initiatives like Project Sanjeevani by Andhra Pradesh and India\u0027s progress in personalized healthcare and genomics. This document primarily focuses on India\u0027s healthcare innovations and global partnerships in health.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=81536\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
Highlights from the 21st CII Health Summit 2024
Score: 50 · Relevant: No
https://www.cii.in/PressreleasesDetail.aspx?id=80352&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:14:50.023963
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Highlights from the 21st CII Health Summit 2024",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ec57d4251bebdb30f9/financial_report.docx",
"release_date": "2024-12-19",
"relevancy_score": 50,
"scraped_at": "2025-12-30T14:58:50.643000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This document is a media release from the Confederation of Indian Industry (CII) detailing the 21st Health Summit held on December 19, 2024, in New Delhi. It highlights discussions around transforming India\u0027s healthcare system by integrating public and private sectors, MedTech innovations, and Indo-Japan collaborations. Key speakers, including government officials and industry leaders, emphasized the importance of medical technology and financing in achieving India\u2019s health goals by 2047.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=80352\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
Indian Public Health Standards for Community Health Centres
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/files/CommunityHealthCentre_2022.pdf
|
Indian Nursing Association
2025-12-30T15:14:48.827858
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Indian Public Health Standards for Community Health Centres",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1eb0d03278c6ddb3110/CommunityHealthCentre_2022.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:58:51.603000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document outlines the Indian Public Health Standards for Community Health Centres as issued by the Ministry of Health \u0026 Family Welfare in 2022. It serves as a guideline for maintaining quality standards in health services across India. The document provides comprehensive details on health service delivery, infrastructure, and policies for public health centers.",
"url": "https://indiannursingcouncil.org/uploads/files/CommunityHealthCentre_2022.pdf"
}
|
|
Anupriya Patel's Address at 21st CII Health Summit
Score: 60 · Relevant: No
https://www.cii.in/PressreleasesDetail.aspx?id=80349&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:14:47.376909
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Anupriya Patel\u0027s Address at 21st CII Health Summit",
"is_relevant": false,
"local_file_path": "",
"release_date": "2024-12-19",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:58:52.640000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This document is a media release from the 21st CII Health Summit where Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel, addressed key issues regarding the MedTech sector in India. The release highlights India\u0027s position in the global medical devices market, government initiatives to boost industry growth, and the role of AI and public-private partnerships in transforming healthcare. It emphasizes initiatives like the Export Promotion Council for Medical Devices and the Scheme for Promotion of Medical Devices Parks to drive innovation and self-reliance in the sector.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=80349\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
CII Statement on PM Modi's Third Term
Score: 50 · Relevant: No
https://www.cii.in/PressreleasesDetail.aspx?id=79740&gid=&SectorID=S000000031®ionid=&conid=&nrid=&StateID=
|
CII Healthcare Council
2025-12-30T15:14:47.174922
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CII Statement on PM Modi\u0027s Third Term",
"is_relevant": false,
"local_file_path": "",
"release_date": "2024-06-10",
"relevancy_score": 50,
"scraped_at": "2025-12-30T14:58:55.852000Z",
"seed_url": "https://www.cii.in/NewsRoom.aspx?enc=prvePUj2bdMtgTmvPwvisYH+5EnGjyGXO9hLECvTuNsMKUsXkHjKcW18rgxyT23JuwlCaZFz6NnxGD4grfeDFo9JoqytnrxcYi0Wp5k098o=",
"summary": "This is a media release from the President of the Confederation of Indian Industry (CII), Mr. Sanjiv Puri, congratulating Prime Minister Narendra Modi on his third consecutive term in office. The statement emphasizes the partnership between the CII and the government in pursuing reforms and economic development, highlighting key areas like healthcare, education, and skill development. The release reflects CII\u0027s outlook on India\u0027s future economic potential under Modi\u0027s leadership.",
"url": "https://www.cii.in/PressreleasesDetail.aspx?id=79740\u0026gid=\u0026SectorID=S000000031\u0026regionid=\u0026conid=\u0026nrid=\u0026StateID="
}
|
|
State of the World Nursing Report 2020
Score: 80 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/1633000434186232812261559bf250cc9.pdf
|
Indian Nursing Association
2025-12-30T15:09:06.831635
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "State of the World Nursing Report 2020",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f9/1633000434186232812261559bf250cc9.pdf",
"release_date": "2025-12-30",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:53:40.841000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document, titled \u0027State of the World\u0027s Nursing 2020: Investing in Education, Jobs and Leadership,\u0027 was published by the World Health Organization. It discusses the critical role of the nursing workforce in achieving health priorities and emphasizes the need for investment in nursing education, jobs, and leadership. The document highlights policies and strategic directions to strengthen the nursing workforce towards achieving the Sustainable Development Goals by 2030.",
"url": "https://indiannursingcouncil.org/uploads/pdf/1633000434186232812261559bf250cc9.pdf"
}
|
|
The Economic Power of Care 2024 Report
Score: 80 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/17217321021751292808669f8c0670936.pdf
|
Indian Nursing Association
2025-12-30T15:09:06.642202
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "The Economic Power of Care 2024 Report",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f5/17217321021751292808669f8c0670936.pdf",
"release_date": "2025-12-30",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:53:43.460000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is the International Nurses Day 2024 report, titled \u0027The Economic Power of Care,\u0027 published by the International Council of Nurses. The report focuses on the vital role of investing in the nursing workforce and its significant economic benefits, advocating for governmental support to enhance health systems globally. It highlights the economic and social returns of investing in nursing, underscoring the need for strategic investments to improve health care delivery, economic growth, and societal well-being.",
"url": "https://indiannursingcouncil.org/uploads/pdf/17217321021751292808669f8c0670936.pdf"
}
|
|
Psychosocial Support Manual for Bereavement During COVID-19
Score: 39 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16203612798196015336094c03f6b943.pdf
|
Indian Nursing Association
2025-12-30T15:09:06.274468
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Psychosocial Support Manual for Bereavement During COVID-19",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30fb/16203612798196015336094c03f6b943.pdf",
"release_date": "2025-12-30",
"relevancy_score": 39,
"scraped_at": "2025-12-30T14:53:43.963000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a manual published by the Indian Council of Medical Research (ICMR) titled \u0027Health Care Professionals in providing Psychosocial Support to family members in bereavement in the time of COVID-19\u0027. It provides guidelines for healthcare professionals on how to manage bereavement among family members of COVID-19 patients, covering topics like disclosing news of death, providing psychosocial support, and self-care for health workers. The manual serves as a guide for healthcare professionals dealing with emotionally charged situations in the context of the pandemic.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16203612798196015336094c03f6b943.pdf"
}
|
|
National Infection Prevention Guidelines for Healthcare Facilities
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16185606081192269929607946602af58.pdf
|
Indian Nursing Association
2025-12-30T15:09:05.844375
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "National Infection Prevention Guidelines for Healthcare Facilities",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30fd/16185606081192269929607946602af58.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:53:44.908000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is the National Guidelines for Infection Prevention and Control in Healthcare Facilities, issued by the Ministry of Health and Family Welfare, Government of India. It covers various aspects such as infection prevention program structure, roles, and responsibilities, and strategies for monitoring and feedback. It is published by the National Centre for Disease Control and includes education and training as well as surveillance strategies.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16185606081192269929607946602af58.pdf"
}
|
|
Corrupted Document Without Coherent Information
Score: 0 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16185605438749231436079461f5da5b.jpg
|
Indian Nursing Association
2025-12-30T15:09:05.455997
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Corrupted Document Without Coherent Information",
"is_relevant": false,
"local_file_path": "",
"release_date": "2025-12-30",
"relevancy_score": 0,
"scraped_at": "2025-12-30T14:53:47.372000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "The document appears to be a corrupted or incomplete text that does not contain readable content about the Indian Nursing Association or any clear information that fits into the user\u0027s categories of interest. No distinct or coherent data can be extracted.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16185605438749231436079461f5da5b.jpg"
}
|
|
Corrupted PDF Document - Arogya Setu App
Score: 0 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16185604851169326082607945e505483.jpg
|
Indian Nursing Association
2025-12-30T15:09:05.224299
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Corrupted PDF Document - Arogya Setu App",
"is_relevant": false,
"local_file_path": "",
"release_date": "2025-12-30",
"relevancy_score": 0,
"scraped_at": "2025-12-30T14:53:47.939000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "The document appears to be a corrupted or improperly extracted PDF file with illegible content. It does not contain any discernible information regarding the Indian Nursing Association or any specific topic of interest such as a news article or official document. Due to its unreadable and corrupted nature, classification is not feasible.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16185604851169326082607945e505483.jpg"
}
|
|
Corrupted Document on Natural Defense Measures
Score: 10 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/161856042026153578607945a404bbd.jpg
|
Indian Nursing Association
2025-12-30T15:09:04.879810
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Corrupted Document on Natural Defense Measures",
"is_relevant": false,
"local_file_path": "",
"release_date": "2025-12-30",
"relevancy_score": 10,
"scraped_at": "2025-12-30T14:53:50.890000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This content appears to be corrupt or not properly formatted, and therefore cannot be fully understood or analyzed. It lacks any discernible text or clear information related to news articles or other specific content. As such, it is unable to provide any meaningful summary or insights.",
"url": "https://indiannursingcouncil.org/uploads/pdf/161856042026153578607945a404bbd.jpg"
}
|
|
Guidance Note for Midwifery Initiative 2019-20
Score: 75 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/161416699893275113460363bd6e0873.pdf
|
Indian Nursing Association
2025-12-30T15:09:03.946447
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Guidance Note for Midwifery Initiative 2019-20",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3103/161416699893275113460363bd6e0873.pdf",
"release_date": "2025-12-30",
"relevancy_score": 75,
"scraped_at": "2025-12-30T14:53:51.694000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a guidance note issued by the Government of India for the planning and implementation of the Midwifery Initiative for the financial year 2019-20. It outlines policy changes, goals, and structural guidelines for establishing and scaling State Midwifery Training Institutes across different states and territories. The document emphasizes training resources, infrastructure requirements, and budgetary support for rolling out midwifery services nationwide.",
"url": "https://indiannursingcouncil.org/uploads/pdf/161416699893275113460363bd6e0873.pdf"
}
|
|
Midwifery Services Guidelines in India 2018
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/1614836390106172094604072a6af631.pdf
|
Indian Nursing Association
2025-12-30T15:09:03.637231
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Midwifery Services Guidelines in India 2018",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3101/1614836390106172094604072a6af631.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:53:54.708000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document consists of guidelines for midwifery services in India, published in 2018. It likely contains detailed regulations or recommendations related to midwifery practice designed for Indian healthcare professionals or organizations. This document is probably intended to standardize or improve the delivery of midwifery services in India.",
"url": "https://indiannursingcouncil.org/uploads/pdf/1614836390106172094604072a6af631.pdf"
}
|
|
Operational Guidelines for Obstetric ICUs and HDUs
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/15992203022454527345f522a4e2cbd0.pdf
|
Indian Nursing Association
2025-12-30T15:09:02.679499
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Operational Guidelines for Obstetric ICUs and HDUs",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3104/15992203022454527345f522a4e2cbd0.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:53:55.461000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document provides operational guidelines for Obstetric Intensive Care Units (ICUs) and High Dependency Units (HDUs) and is issued by the Ministry of Health \u0026 Family Welfare, Government of India. It outlines the efforts and initiatives under the National Health Mission to improve maternal health and reduce maternal mortality in India, including the development of standardized labor rooms under the LaQshya program. The guidelines aim to assist program managers in implementing these facilities across India.",
"url": "https://indiannursingcouncil.org/uploads/pdf/15992203022454527345f522a4e2cbd0.pdf"
}
|
|
Guidelines for Standardizing Delivery Room Procedures
Score: 0 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/159922030210173681855f522a4e29c9b.pdf
|
Indian Nursing Association
2025-12-30T15:09:02.441918
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Guidelines for Standardizing Delivery Room Procedures",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30fa/159922030210173681855f522a4e29c9b.pdf",
"release_date": "2025-12-30",
"relevancy_score": 0,
"scraped_at": "2025-12-30T14:53:55.625000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "The document appears to be a publication or report updated in April 2016. It does not contain any identifiable news article text or content related to the Indian Nursing Association\u0027s interests. The document primarily states its update timeline without detailing any specific information beyond that.",
"url": "https://indiannursingcouncil.org/uploads/pdf/159922030210173681855f522a4e29c9b.pdf"
}
|
|
LAQSHYA Initiative: Labour Room Quality Improvement Overview
Score: 20 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/15992203028568996565f522a4e28429.pdf
|
Indian Nursing Association
2025-12-30T15:08:58.676297
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "LAQSHYA Initiative: Labour Room Quality Improvement Overview",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3105/15992203028568996565f522a4e28429.pdf",
"release_date": "2025-12-30",
"relevancy_score": 20,
"scraped_at": "2025-12-30T14:53:56.543000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "The document appears to be related to the National Health Mission, but detailed content from the five sampled pages is insufficient to provide specific insights into the nature of the document. It may include information about public health strategies or policies under the National Health Mission, but without additional context, this is uncertain.",
"url": "https://indiannursingcouncil.org/uploads/pdf/15992203028568996565f522a4e28429.pdf"
}
|
|
COVID-19 Human Resource Management Advisory
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16185607784758798756079470ad1eda.pdf
|
Indian Nursing Association
2025-12-30T15:08:54.017809
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "COVID-19 Human Resource Management Advisory",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3107/16185607784758798756079470ad1eda.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:53:56.691000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This is an advisory document from the Ministry of Health \u0026 Family Welfare\u0027s Directorate General of Health Services, outlining human resource management strategies for COVID-19 containment efforts in India. It provides guidance on mobilizing and training human resources for activities such as surveillance, clinical management, and psycho-social care. The document also includes capacity building measures and training resources for various healthcare professionals and volunteers involved in COVID-19 response.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16185607784758798756079470ad1eda.pdf"
}
|
|
Guidelines for Frontline Workers on COVID-19 Prevention
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16185607472116129392607946ebebb2e.pdf
|
Indian Nursing Association
2025-12-30T15:08:53.774184
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Guidelines for Frontline Workers on COVID-19 Prevention",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3108/16185607472116129392607946ebebb2e.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:53:57.759000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a guideline issued for frontline health workers, detailing practices to prevent the spread of COVID-19. It outlines measures such as social distancing, hygiene practices, and quarantine protocols to be followed. The document emphasizes the crucial role of community workers in disseminating information and monitoring for potential cases.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16185607472116129392607946ebebb2e.pdf"
}
|
|
COVID-19 Education Resource for Auxiliary Nurse Midwives
Score: 60 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/161856081016696730216079472a08ee4.pdf
|
Indian Nursing Association
2025-12-30T15:08:53.557688
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "COVID-19 Education Resource for Auxiliary Nurse Midwives",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3106/161856081016696730216079472a08ee4.pdf",
"release_date": "2025-12-30",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:53:58.089000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a learning resource package aimed at Auxiliary Nurse Midwives (ANMs) in India, focused on healthcare transformation and COVID-19 education. It discusses the definition, symptoms, and prevention measures of COVID-19, as well as the methodology for educating communities and coordinating with healthcare workers. The document references an update on COVID-19 provided by the WHO as of March 17, 2020.",
"url": "https://indiannursingcouncil.org/uploads/pdf/161856081016696730216079472a08ee4.pdf"
}
|
|
Midwifery Initiative Rollout Guidelines for States
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/161416699886773495860363bd6e0ee3.pdf
|
Indian Nursing Association
2025-12-30T15:08:52.787585
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Midwifery Initiative Rollout Guidelines for States",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3102/161416699886773495860363bd6e0ee3.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:53:58.598000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a communication from the Ministry of Health \u0026 Family Welfare, Government of India, regarding the rollout of a Midwifery Initiative in Indian states. It emphasizes the importance of skilled midwifery in improving maternal and newborn health and introduces the concept of Midwifery Led Care Units. The guidelines and a guidance note are provided for states to plan and implement the initiative.",
"url": "https://indiannursingcouncil.org/uploads/pdf/161416699886773495860363bd6e0ee3.pdf"
}
|
|
COVID-19 Guidance: Rights and Safety for Health Workers
Score: 60 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16185607151594802284607946cb67f88.pdf
|
Indian Nursing Association
2025-12-30T15:08:52.077615
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "COVID-19 Guidance: Rights and Safety for Health Workers",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb3109/16185607151594802284607946cb67f88.pdf",
"release_date": "2025-12-30",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:53:58.646000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is an interim guidance paper issued by the World Health Organization on March 19, 2020, detailing the rights, roles, and responsibilities of health workers during the COVID-19 outbreak. It highlights key considerations for occupational safety and health to mitigate risk exposure, manage stress, and enhance workplace safety measures. It includes recommendations for both employers and workers on protective protocols and rights in the healthcare setting.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16185607151594802284607946cb67f88.pdf"
}
|
|
Zoom Link for Nurse Midwife Campaign Launch
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/163300110798771472861559e93b6158.pdf
|
Indian Nursing Association
2025-12-30T15:08:49.010357
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Zoom Link for Nurse Midwife Campaign Launch",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb310b/163300110798771472861559e93b6158.pdf",
"release_date": "2021-09-02",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:58:34.317000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document contains a Zoom link but lacks details about its purpose or context. It does not provide any information regarding a news article or a specified nursing-related topic.",
"url": "https://indiannursingcouncil.org/uploads/pdf/163300110798771472861559e93b6158.pdf"
}
|
|
WHO Resolution on Nursing Midwifery Strategy 2021
Score: 80 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/163300043478264270661559bf251ad1.pdf
|
Indian Nursing Association
2025-12-30T15:08:48.153918
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "WHO Resolution on Nursing Midwifery Strategy 2021",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb310c/163300043478264270661559bf251ad1.pdf",
"release_date": "2021-05-31",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:58:35.377000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a resolution from the Seventy-fourth World Health Assembly, focusing on strengthening the nursing and midwifery sectors by investing in education, jobs, leadership, and service delivery. It highlights the critical role nurses and midwives play in health systems, especially during the COVID-19 pandemic, and emphasizes achieving Sustainable Development Goals such as universal health coverage. Key actions include addressing workforce shortages, distribution issues, and the need for supportive work environments.",
"url": "https://indiannursingcouncil.org/uploads/pdf/163300043478264270661559bf251ad1.pdf"
}
|
|
WHO Guidance on Infection Control for COVID-19
Score: 0 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/1618560682575373349607946aacf9ed.pdf
|
Indian Nursing Association
2025-12-30T15:08:47.973357
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "WHO Guidance on Infection Control for COVID-19",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1ea0d03278c6ddb310a/1618560682575373349607946aacf9ed.pdf",
"release_date": "2025-12-30",
"relevancy_score": 0,
"scraped_at": "2025-12-30T14:58:36.136000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is an interim guidance issued by the World Health Organization (WHO) on infection prevention and control strategies to be used when COVID-19 is suspected in healthcare settings. It outlines various IPC strategies such as early recognition, isolation, application of standard precautions, and use of personal protective equipment (PPE) to limit transmission of the virus. The document aims to assist healthcare workers, managers, and IPC teams at facility, national, and district/provincial levels.",
"url": "https://indiannursingcouncil.org/uploads/pdf/1618560682575373349607946aacf9ed.pdf"
}
|
|
2012 Revised Guidelines for District Hospitals in India
Score: 40 · Relevant: No
https://indiannursingcouncil.org/uploads/files/DistrictHospitals.pdf
|
Indian Nursing Association
2025-12-30T15:08:47.671819
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "2012 Revised Guidelines for District Hospitals in India",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1eb0d03278c6ddb3112/DistrictHospitals.pdf",
"release_date": "2025-12-30",
"relevancy_score": 40,
"scraped_at": "2025-12-30T14:58:41.159000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document consists of the 2012 revised guidelines for district hospitals in India, prepared by the Directorate General of Health Services, Ministry of Health \u0026 Family Welfare, Government of India. It covers various aspects of hospital management, including objectives, functions, services, infrastructure, manpower, and statutory compliance among others for hospitals with 101 to 500 beds. The guidelines aim to set standards for effective public health management.",
"url": "https://indiannursingcouncil.org/uploads/files/DistrictHospitals.pdf"
}
|
|
Key Leadership Insights from ICN Congress Masterclass
Score: 80 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/17217328241559883961669f8ed8bbe9b.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.902692
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "news_article",
"generated_title": "Key Leadership Insights from ICN Congress Masterclass",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f2/17217328241559883961669f8ed8bbe9b.pdf",
"release_date": "2025-12-30",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:53:35.075000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is an article summarizing a leadership masterclass at the ICN Congress in Montreal, featuring speaker Simon Sinek and Canadian Chief Nurse Leigh Chapman. The session focused on the importance of leadership in healthcare, emphasizing empathy, realistic perspectives, and ongoing leadership development for nurses. The article outlines actionable insights for improving leadership among healthcare professionals, including creating support systems and recognizing the role of vulnerable yet transformative work.",
"url": "https://indiannursingcouncil.org/uploads/pdf/17217328241559883961669f8ed8bbe9b.pdf"
}
|
|
ICN Calls for Humane Treatment of Migrants
Score: 80 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/17217328241802768073669f8ed8bb26b.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.870755
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "news_article",
"generated_title": "ICN Calls for Humane Treatment of Migrants",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f4/17217328241802768073669f8ed8bb26b.pdf",
"release_date": "2025-12-30",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:53:35.545000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a news article reporting on an emergency resolution passed by the ICN (International Council of Nurses) demanding humane treatment for migrants. The resolution, proposed by the Norwegian Nurses Organisation, addresses human rights violations against migrants amidst increasing migration patterns, including among nurses. The ICN calls for global political action and urges stakeholders to adopt measures from the WHO Global Action Plan and the Rabat Declaration to improve migrant health care and rights.",
"url": "https://indiannursingcouncil.org/uploads/pdf/17217328241802768073669f8ed8bb26b.pdf"
}
|
|
Agenda and Invitation for #NurseMidwife4Change Campaign
Score: 60 · Relevant: No
https://indiannursingcouncil.org/uploads/files/16608977958251.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.867210
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Agenda and Invitation for #NurseMidwife4Change Campaign",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f0/16608977958251.pdf",
"release_date": "2022-08-22",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:53:35.798000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is an agenda and invitation for the #NurseMidwife4Change online campaign, organized by Jhpiego and the Indian Nursing Council. The event, aimed at advocacy and action for nurses, is scheduled for August 22nd and details various sessions including keynote speeches, panel discussions, and a Q\u0026A round. Key figures in nursing and healthcare will speak, and the event will be streamed online.",
"url": "https://indiannursingcouncil.org/uploads/files/16608977958251.pdf"
}
|
|
Message from ICN President on Nursing Challenges
Score: 60 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/1651223016448757455626ba9e87d511.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.823155
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Message from ICN President on Nursing Challenges",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f8/1651223016448757455626ba9e87d511.pdf",
"release_date": "2025-12-30",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:53:36.468000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a message from Dr Pamela F. Cipriano, President of the International Council of Nurses, discussing the challenges faced by nurses worldwide, especially during the COVID-19 pandemic. It highlights important reports such as the World Health Organization\u0027s State of the World\u0027s Nursing report and WHO\u0027s Global Strategic Directions for Nursing and Midwifery 2021-2025. The document calls for investment in the nursing workforce to address issues like global nursing shortages and underinvestment in nursing education and leadership.",
"url": "https://indiannursingcouncil.org/uploads/pdf/1651223016448757455626ba9e87d511.pdf"
}
|
|
WHO Announces 2025 Nursing Report at ICN Congress
Score: 90 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/1721732824781078346669f8ed8bb8e2.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.725940
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "news_article",
"generated_title": "WHO Announces 2025 Nursing Report at ICN Congress",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f3/1721732824781078346669f8ed8bb8e2.pdf",
"release_date": "2025-12-30",
"relevancy_score": 90,
"scraped_at": "2025-12-30T14:53:36.497000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This news article discusses a major announcement made by WHO Director General Dr. Tedros Adhanom Ghebreyesus at the ICN Congress in Montreal regarding the launch of the second State of the World\u2019s Nursing report in 2025. The announcement addresses the global shortage of nurses and the need for accurate workforce data post-COVID-19. The article emphasizes the importance of collaboration with ICN and National Nursing Associations to improve nursing education, employment, and retention globally.",
"url": "https://indiannursingcouncil.org/uploads/pdf/1721732824781078346669f8ed8bb8e2.pdf"
}
|
|
Gender Pay Gap and Underfunding in Nursing
Score: 90 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/1721728502404097452669f7df6c40d3.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.719612
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "news_article",
"generated_title": "Gender Pay Gap and Underfunding in Nursing",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f6/1721728502404097452669f7df6c40d3.pdf",
"release_date": "2025-12-30",
"relevancy_score": 90,
"scraped_at": "2025-12-30T14:53:37.383000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This news article from the International Council of Nurses (ICN) highlights reports revealing significant gender pay gaps in the nursing and health sectors, where women earn 24% less than their male counterparts. The article discusses the undervaluing and underfunding of nursing, a predominantly female profession, and calls for systemic changes in pay models and working conditions. It further emphasizes the urgent need for investment in nursing to counteract workforce shortages exacerbated by the COVID-19 pandemic.",
"url": "https://indiannursingcouncil.org/uploads/pdf/1721728502404097452669f7df6c40d3.pdf"
}
|
|
Nurses' Advocacy: A Voice to Lead 2022
Score: 39 · Relevant: No
https://indiannursingcouncil.org/uploads/pdf/16512230161890018546626ba9e87dc96.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.550977
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Nurses\u0027 Advocacy: A Voice to Lead 2022",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f7/16512230161890018546626ba9e87dc96.pdf",
"release_date": "2022-05-12",
"relevancy_score": 39,
"scraped_at": "2025-12-30T14:53:37.834000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document, issued by the International Council of Nurses, focuses on the importance of investing in nursing and respecting nurses\u0027 rights to ensure global health. It emphasizes the theme \"Nurses: A Voice to Lead\" and highlights key hashtags like #IND2022 and #VoiceToLead, underscoring a call to action for the nursing community. The repetition across multiple pages suggests it might be intended for promotional or campaign use.",
"url": "https://indiannursingcouncil.org/uploads/pdf/16512230161890018546626ba9e87dc96.pdf"
}
|
|
State of the World Nursing Report 2025
Score: 70 · Relevant: Yes
https://indiannursingcouncil.org/uploads/pdf/175041085738937483268552669e31be.pdf
|
Indian Nursing Association
2025-12-30T15:03:47.539484
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "State of the World Nursing Report 2025",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30f1/175041085738937483268552669e31be.pdf",
"release_date": "2025-12-30",
"relevancy_score": 70,
"scraped_at": "2025-12-30T14:53:40.831000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is a comprehensive report titled \u0027State of the World\u2019s Nursing 2025\u0027, issued by the World Health Organization. It focuses on investment in nursing education, jobs, leadership, and service delivery. The report aims to address global health workforce challenges and provides policy directions through 2030.",
"url": "https://indiannursingcouncil.org/uploads/pdf/175041085738937483268552669e31be.pdf"
}
|
|
CDSCO FAQ on New Phytopharmaceutical Drugs Approval
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MA==
|
CDSCO - New Drugs
2025-12-30T14:58:56.352823
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CDSCO FAQ on New Phytopharmaceutical Drugs Approval",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d43c/Phyto.pdf",
"release_date": "2014-01-04",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:23.884000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document, issued by the Central Drugs Standard Control Organization (CDSCO), provides a comprehensive set of frequently asked questions (FAQs) regarding the approval of new phytopharmaceutical drugs in India. It explains the definition of these drugs, the conditions under which they are considered new, and the process for clinical trials and permissions. The document aims to promote public awareness about the regulations but urges readers to refer to statutory provisions for legal advice.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MA=="
}
|
|
Draft Guidelines for Reporting Serious Adverse Events
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1MA==
|
CDSCO - New Drugs
2025-12-30T14:58:56.297864
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Draft Guidelines for Reporting Serious Adverse Events",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d43b/SAEGUIDELINES552011.pdf",
"release_date": "2014-01-04",
"relevancy_score": 100,
"scraped_at": "2025-12-16T21:36:24.373000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance from the Central Drugs Standard Control Organization (CDSCO) on reporting serious adverse events occurring in clinical trials. It is intended to standardize the reporting process for pharmaceutical companies and contract research organizations, ensuring uniformity and completeness in the data submitted. The document details responsibilities, timelines, and includes templates for reporting these events to the Drugs Controller General (India).",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1MA=="
}
|
|
Updated Advisory on Empagliflozin Tablets Safety Warnings
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MQ==
|
CDSCO - New Drugs
2025-12-30T14:58:56.245498
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "advisory",
"generated_title": "Updated Advisory on Empagliflozin Tablets Safety Warnings",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d439/Empagliflozin.pdf",
"release_date": "2014-01-04",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:28.900000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "The document issued by the Directorate General of Health Services at CDSCO is an advisory regarding the updated package insert for Empagliflozin tablets due to revised safety communications from the US FDA. It highlights the added warnings about the risks of diabetic ketoacidosis and serious urinary tract infections associated with the drug. This advisory is directed to all state drug controllers and related organizations.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MQ=="
}
|
|
2013 Approved Drug List for India
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Ng==
|
CDSCO - New Drugs
2025-12-30T14:58:56.187957
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "2013 Approved Drug List for India",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d43e/New2013.pdf",
"release_date": "2013-11-27",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:29.801000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a detailed list issued by an authority, likely related to the Indian government, of approved drugs from January 1, 2013, to December 31, 2013. It includes information about various drugs, their approved indications, and the date of approval. The list is comprehensive and provides insights into the spectrum of medications and their therapeutic uses approved during 2013.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Ng=="
}
|
|
July 2013 Report on Drug Approval Guidelines
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OA==
|
CDSCO - New Drugs
2025-12-30T14:58:56.122218
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "July 2013 Report on Drug Approval Guidelines",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d43f/Report_of_Dr_Ranjit_Roy.pdf",
"release_date": "2013-07-23",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:30.453000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a report from the Prof. Ranjit Roy Chaudhury Expert Committee, which outlines policy and guidelines for the approval of new drugs, clinical trials, and the banning of drugs in India. It includes detailed recommendations for the accreditation of clinical trial centers and investigators, the establishment of a Central Accreditation Council, and guidelines for informed consent and compensation in clinical trials. The report is highly relevant for stakeholders in new drug approvals and clinical trial processes in India.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OA=="
}
|
|
CDSCO Draft Guidance on Chemical Information Requirements
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OQ==
|
CDSCO - New Drugs
2025-12-30T14:58:56.069276
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CDSCO Draft Guidance on Chemical Information Requirements",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d440/GuidanceCMCStabilityData.pdf",
"release_date": "2012-07-27",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:34.418000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a guidance issued by the Central Drugs Standard Control Organization (CDSCO) regarding the requirements for chemical and pharmaceutical information, including stability study data, needed before the approval of clinical trials and bioequivalence studies. It details the necessary data that must be submitted to assess the safety and quality of investigational drug products. The document sets out the regulatory framework and expectations for new drug formulations under the Drugs and Cosmetics Rules in India.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OQ=="
}
|
|
CDSCO Draft Guidance on Clinical Trial Data Requirements
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDk=
|
CDSCO - New Drugs
2025-12-30T14:58:56.016323
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CDSCO Draft Guidance on Clinical Trial Data Requirements",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d442/Guidance CMC _ Stability Data.pdf",
"release_date": "2018-02-09",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:34.858000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance from the Central Drugs Standard Control Organization (CDSCO) providing guidelines for the required chemical and pharmaceutical information, including stability study data, necessary before the approval of clinical trials or bioequivalence studies. It outlines the regulatory requirements under the Drugs and Cosmetics Rules for new drug applications, aiming to ensure the safety and quality of clinical trials. Stakeholders are invited to provide feedback within 30 days of its publication.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDk="
}
|
|
Draft Policy for New Drug Approval in India
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTM2Nw==
|
CDSCO - New Drugs
2025-12-30T14:58:55.941162
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Draft Policy for New Drug Approval in India",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d441/DRAFT POLICY FOR APPROVAL OF NEW DRUGS.pdf",
"release_date": "2022-11-25",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:35.075000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This is a draft policy document issued by the Central Drugs Standard Control Organization (CDSCO) detailing the processes and requirements for the approval of new drugs in India. It outlines policies for new drug applications, clinical trials, and the evaluation of new drug safety and efficacy. The document emphasizes the importance of regulatory transparency and the use of global clinical data in the approval process.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTM2Nw=="
}
|
|
Regulatory Guidelines for Synthetic Drug Approval
Score: 85 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0MQ==
|
CDSCO - New Drugs
2025-12-30T14:58:52.694386
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "Regulatory Guidelines for Synthetic Drug Approval",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d444/Guidelines for approval of synthetically manufactured drug which has been previously approved as r-DNA derived drug..pdf",
"release_date": "2020-03-13",
"relevancy_score": 85,
"scraped_at": "2025-12-16T21:36:35.161000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This public notice issued by the Central Drugs Standard Control Organization outlines the regulatory guidelines for the approval of synthetically manufactured drugs that have been previously approved as r-DNA derived drugs. The notice specifies the requirement for applications to be submitted as subsequent new drugs under the New Drugs and Clinical Trials Rules, 2019. This applies to both synthetic peptides and non-biological products.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0MQ=="
}
|
|
New Drug Testing Requirements Public Notice 2023
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0NA==
|
CDSCO - New Drugs
2025-12-30T14:58:51.657264
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "New Drug Testing Requirements Public Notice 2023",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d445/Testing of all categories of new drugs for their approval.pdf",
"release_date": "2020-03-13",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:36:35.360000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This is a public notice issued by the Drugs Controller General of India from the Central Drugs Standard Control Organization (CDSCO). It addresses the testing requirements for new drugs under the New Drugs and Clinical Trials Rules, 2019, highlighting the streamlined timelines for testing at Central Government Laboratories. The notice is intended for government laboratories and all stakeholders involved in drug approval processes.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0NA=="
}
|
|
CDSCO Notice on Process Validation for Clinical Trials
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mw==
|
CDSCO - New Drugs
2025-12-30T14:58:50.699174
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CDSCO Notice on Process Validation for Clinical Trials",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d446/Requirement of process validation report for permission to conduct Clinical trial BA-BE studies..pdf",
"release_date": "2020-03-13",
"relevancy_score": 100,
"scraped_at": "2025-12-16T21:36:37.908000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a notice issued by the Central Drugs Standard Control Organization (CDSCO) through the Directorate General of Health Services regarding the requirement of process validation reports for clinical trial approvals under the New Drugs and Clinical Trials Rules, 2019. It clarifies that for Phase I and II clinical trials, process validation is not required similarly to commercial batches, with Phase III requirements varying by product complexity. Dr. V.G. Somani, the Drugs Controller General (India), addresses this notice to all stakeholders.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mw=="
}
|
|
CMC Document Requirements for Additional Drug Indications
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mg==
|
CDSCO - New Drugs
2025-12-30T14:58:50.479798
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CMC Document Requirements for Additional Drug Indications",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d447/Requirement of CMC documents for approval of additional indication of an already drug product.pdf",
"release_date": "2020-03-13",
"relevancy_score": 100,
"scraped_at": "2025-12-16T21:36:41.828000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a notice from the Central Drugs Standard Control Organization (CDSCO), issued by the Drugs Controller General of India, regarding the requirement of Chemistry, Manufacturing, and Controls (CMC) documents for approval of additional indications of an already approved drug. It outlines the conditions under which CMC data may be omitted as per the New Drugs and Clinical Trials Rules, 2019, depending on existing approvals and marketing status within India.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mg=="
}
|
|
New Drugs and Clinical Trials Rules 2019 Notification
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDI2MQ==
|
CDSCO - New Drugs
2025-12-30T14:58:49.357186
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "order",
"generated_title": "New Drugs and Clinical Trials Rules 2019 Notification",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d026c6178ad47676d44c/gsr227e.pdf",
"release_date": "2019-03-20",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:36:46.789000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "The document is an official government notification published in part II, section 3, sub-section (i) of the Extraordinary Gazette of India, dated March 19, 2019. It details the New Drugs and Clinical Trials Rules, 2019, and outlines definitions and provisions related to new drugs, clinical trials, bioavailability, and bioequivalence studies among others. This is a directive issued by the Central Government under the Drugs and Cosmetics Act, 1940.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDI2MQ=="
}
|
|
Impurity Limits for Investigational New Drugs
Score: 85 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc5NA==
|
CDSCO - New Drugs
2025-12-30T14:58:49.190836
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Impurity Limits for Investigational New Drugs",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d448/fixingINDs.pdf",
"release_date": "2020-02-21",
"relevancy_score": 85,
"scraped_at": "2025-12-16T21:36:49.456000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is an official communication from the Drugs Controller General (India) regarding the establishment of impurity limits in the specification of Investigational New Drugs (INDs). It provides insights into the processing and consideration of clinical trial applications by the CDSCO. The document originates from the office of the Drugs Standard Control Organization, emphasizing regulatory aspects of new drug development.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc5NA=="
}
|
|
CDSCO Draft Guidance for New Drug Applications
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTE=
|
CDSCO - New Drugs
2025-12-30T14:58:48.666790
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CDSCO Draft Guidance for New Drug Applications",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d026c6178ad47676d44d/CTD Guidance Final.pdf",
"release_date": "2018-02-09",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:49.589000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance from the Central Drugs Standard Control Organization (CDSCO) in India, providing instructions for the preparation of a Common Technical Document (CTD) for the import, manufacture, and marketing approval of new drugs for human use. It details the background, scope, and guidelines for organizing data to facilitate regulatory review and alignment with international standards. Feedback on the draft was solicited with a 60-day comment period following its release.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTE="
}
|
|
Withdrawal Notice for Olaparib Indications in Ovarian Cancer
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTEyNjk=
|
CDSCO - New Drugs
2025-12-30T14:58:46.274925
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "Withdrawal Notice for Olaparib Indications in Ovarian Cancer",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d443/All State-UTs Drugs Controller Olaparib Withdrawal.pdf",
"release_date": "2024-05-16",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:37:10.544000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a public notice issued by the Central Drugs Standard Control Organization (CDSCO) informing about the withdrawal of specific indications for Olaparib Tablets 100mg and 150mg. These indications were previously approved for treating patients with gBRCA mutation and advanced ovarian cancer after three or more chemotherapy lines. The decision was based on clinical evidence suggesting a potential detrimental effect on overall survival for these patients, and consequently, manufacturers are instructed to withdraw the marketing of these indications and submit revised package inserts.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTEyNjk="
}
|
|
Advisory on FDC Safety and Efficacy Compliance
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mg==
|
CDSCO - New Drugs
2025-12-30T14:58:45.941242
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "advisory",
"generated_title": "Advisory on FDC Safety and Efficacy Compliance",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d026c6178ad47676d44f/CircularRegardingApprovalfdcwithoutapprovaldcgi.pdf",
"release_date": "2014-02-03",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:37:14.010000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is an advisory from the Drugs Controller General (India) requesting all State and UT Drugs Controllers to ensure that manufacturers of Fixed Dose Combinations (FDCs) provide safety and efficacy evidence for those FDCs approved without due authorization. The document prompts manufacturers to submit necessary applications and documents to the CDSCO for review by an Expert Committee.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mg=="
}
|
|
CDSCO Update on New Drugs and Trials FAQs
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTU4OA==
|
CDSCO - New Drugs
2025-12-30T14:58:45.552119
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CDSCO Update on New Drugs and Trials FAQs",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d026c6178ad47676d44a/notice18.2.2020faqnew.pdf",
"release_date": "2020-02-18",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:37:20.208000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a public notice from the Central Drug Standard Control Organization (CDSCO) in India. It updates the FAQs regarding the New Drugs \u0026 Clinical Trial Rules 2019 and addresses concerns related to the applicability of these rules and the submission process for obtaining permission to manufacture trial batches of new drugs. Key updates include clarifications on where to submit applications and modifications to several frequently asked questions.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTU4OA=="
}
|
|
Updated FAQs on New Drugs and Clinical Trials
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc4OQ==
|
CDSCO - New Drugs
2025-12-30T14:58:45.477227
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "Updated FAQs on New Drugs and Clinical Trials",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d026c6178ad47676d44b/noticefaqnewdrug.pdf",
"release_date": "2020-02-18",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:37:27.907000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This public notice from the CDSCO provides updated FAQs related to the New Drugs and Clinical Trials Rules, 2019. It addresses applicability concerns about these rules for non-new drugs, the process for obtaining manufacturing permission for investigational drug trials, and necessary approvals for BA/BE studies. Key clarifications are made on submission procedures and regulatory requirements for drugs under these rules.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc4OQ=="
}
|
|
CDSCO Notices on New Drug Applications and Trials
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTYyMg==
|
CDSCO - New Drugs
2025-12-30T14:58:41.213187
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CDSCO Notices on New Drug Applications and Trials",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d026c6178ad47676d449/NoticesforStreamliningcopp.pdf",
"release_date": "2020-02-21",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:37:42.491000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document consists of multiple notices issued by the Directorate General of Health Services, CDSCO, regarding the processing of applications related to clinical trials, the approval of Fixed Dose Combinations (FDCs), the fixing of impurity limits for Investigational New Drugs (INDs), and guidelines for required meetings prior to application submissions. The notices clarify the rules under the New Drugs and Clinical Trials Rules 2019, addressing concerns raised by stakeholders on these topics. Each notice is signed by Dr. V.G. Somani, the Drugs Controller General of India.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTYyMg=="
}
|
|
Formation of New Drug Advisory Committee Order
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1Mg==
|
CDSCO - New Drugs
2025-12-30T14:58:36.195911
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "order",
"generated_title": "Formation of New Drug Advisory Committee Order",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d43d/newdrug_advisory_commitee.pdf",
"release_date": "2014-01-04",
"relevancy_score": 90,
"scraped_at": "2025-12-16T21:37:42.598000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is an official order from the Government of India\u0027s Ministry of Health \u0026 Family Welfare, dated March 31, 2011. It announces the formation of the New Drug Advisory Committee (NDAC) to advise the Drugs Controller General of India in matters related to the review and approval of new drug applications and clinical trials. The document outlines the committee\u0027s composition, terms of reference, and responsibilities, including the evaluation of pharmacological and toxicological data and ensuring no conflicts of interest among its members.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1Mg=="
}
|
|
Establishment of New Drug Advisory Committee Order
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTY=
|
CDSCO - New Drugs
2025-12-30T14:58:35.622476
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "order",
"generated_title": "Establishment of New Drug Advisory Committee Order",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d026c6178ad47676d44e/newdrug_advisory_commitee.pdf",
"release_date": "2018-02-09",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:37:50.935000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This order, issued by the Ministry of Health \u0026 Family Welfare, Government of India, details the constitution of the New Drug Advisory Committee (NDAC) to advise the Drugs Controller General of India in matters regarding the review of new drug applications and clinical trials. It includes the composition of the committee and outlines its terms of reference, such as evaluating clinical trial data and providing guidelines for new drug approvals. The document is dated March 31, 2011.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTY="
}
|
|
Indian Nursing Council Act Summary 1947
Score: 80 · Relevant: Yes
https://indiannursingcouncil.org/uploads/files/16141575032256.pdf
|
Indian Nursing Association
2025-12-30T14:58:35.527449
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Indian Nursing Council Act Summary 1947",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30ed/16141575032256.pdf",
"release_date": "2025-12-30",
"relevancy_score": 80,
"scraped_at": "2025-12-30T14:48:56.939000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document is the text of the Indian Nursing Council Act, 1947, which establishes the Indian Nursing Council to standardize the training of nurses, midwives, and health visitors across India. It outlines the composition, roles, and powers of the council, as well as the procedures for elections and terms of office for its members. The Act mandates a uniform standard of training and provides for the constitution of state registers and councils.",
"url": "https://indiannursingcouncil.org/uploads/files/16141575032256.pdf"
}
|
|
Overview of Nursing Now Campaign Launch Activities
Score: 60 · Relevant: No
https://indiannursingcouncil.org/uploads/files/15991333604352.pdf
|
Indian Nursing Association
2025-12-30T14:58:35.408223
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Overview of Nursing Now Campaign Launch Activities",
"is_relevant": false,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30ee/15991333604352.pdf",
"release_date": "2025-12-30",
"relevancy_score": 60,
"scraped_at": "2025-12-30T14:48:59.011000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "This document describes conferences and workshops organized by the Indian Nursing Council (INC) in collaboration with international entities like Jhpiego and Laerdal Medical India. It covers the launch of the \u0027Nursing Now\u0027 campaign in India at various events attended by international delegates and Indian dignitaries. Additionally, the document details a Central Selection Committee meeting related to nursing awards and the signing of a Memorandum of Understanding with the Burdett Trust for Nursing.",
"url": "https://indiannursingcouncil.org/uploads/files/15991333604352.pdf"
}
|
|
Launch of 'Nursing Now' Campaign in India 2018
Score: 100 · Relevant: Yes
https://indiannursingcouncil.org/uploads/files/15991335094701.pdf
|
Indian Nursing Association
2025-12-30T14:58:35.106970
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Launch of \u0027Nursing Now\u0027 Campaign in India 2018",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6953e1e90d03278c6ddb30ef/15991335094701.pdf",
"release_date": "2025-12-30",
"relevancy_score": 100,
"scraped_at": "2025-12-30T14:49:05.374000Z",
"seed_url": "https://indiannursingcouncil.org/government-of-india-who-international-council-of-nurses-icn-other-stakeholders-guidelines-reports-policies",
"summary": "The document is an announcement from the Indian Nursing Council about the launch of the \u0027Nursing Now\u0027 campaign in India, which took place from November 29 to December 1, 2018. This global campaign, backed by the World Health Organization and the International Council of Nurses, aims to enhance the status and involvement of nurses in health policy and leadership roles. It outlines key areas of focus such as policy-making, investment, leadership, research, and sharing best practices, contributing to global health improvement and Universal Health Coverage.",
"url": "https://indiannursingcouncil.org/uploads/files/15991335094701.pdf"
}
|
|
Draft Policy for New Drug Approval in India
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTM2Nw==
|
CDSCO - New Drugs
2025-12-30T14:53:54.828377
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Draft Policy for New Drug Approval in India",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc6/DRAFT POLICY FOR APPROVAL OF NEW DRUGS.pdf",
"release_date": "2022-11-25",
"relevancy_score": 100,
"scraped_at": "2025-12-15T05:26:57.455000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document, issued by the Central Drugs Standard Control Organization under the Ministry of Health \u0026 Family Welfare, outlines the draft policy for the approval of new drugs in India. It details the process for new drug applications, including pre-submission discussions, necessary evaluations, and considerations for local and global clinical data. The document aims to establish clear regulatory procedures to ensure the safety and effectiveness of new drugs.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTM2Nw=="
}
|
|
Prof. Ranjit Roy Chaudhury Committee Report on Drug Policies
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OA==
|
CDSCO - New Drugs
2025-12-30T14:53:54.792164
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Prof. Ranjit Roy Chaudhury Committee Report on Drug Policies",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc4/Report_of_Dr_Ranjit_Roy.pdf",
"release_date": "2013-07-23",
"relevancy_score": 80,
"scraped_at": "2025-12-15T05:26:57.691000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This is a report from the Prof. Ranjit Roy Chaudhury Expert Committee, tasked with formulating policy and guidelines for new drug approvals, clinical trials, and the banning of drugs. It includes recommendations for the accreditation of trial institutions, consent requirements, and compensation protocols. The report was intended to guide the development of policies by the Drugs Controller General of India and other stakeholders in clinical research.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OA=="
}
|
|
CDSCO Notice on Process Validation for Clinical Trials
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mw==
|
CDSCO - New Drugs
2025-12-30T14:53:54.761582
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CDSCO Notice on Process Validation for Clinical Trials",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6ccb/Requirement of process validation report for permission to conduct Clinical trial BA-BE studies..pdf",
"release_date": "2020-03-13",
"relevancy_score": 100,
"scraped_at": "2025-12-15T05:26:58.267000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This is a public notice issued by the Central Drugs Standard Control Organization (CDSCO) on the requirements for process validation reports for clinical trial/BA-BE studies under the New Drugs and Clinical Trials Rules, 2019. It clarifies the data submissions needed for clinical trial applications and specifies that process validation for commercial batches may not be required for early-phase studies, although proof of process standardization might be necessary. The notice is aimed at stakeholders in the drug approval process.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mw=="
}
|
|
New Drugs and Clinical Trials Rules 2019 Notice
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDI2MQ==
|
CDSCO - New Drugs
2025-12-30T14:53:54.669201
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "New Drugs and Clinical Trials Rules 2019 Notice",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cd2/gsr227e.pdf",
"release_date": "2019-03-20",
"relevancy_score": 100,
"scraped_at": "2025-12-15T05:27:02.930000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a public notice published in the Gazette of India, Extraordinary Issue, concerning the Drugs and Cosmetics Act, 1940. Issued by the Ministry of Health and Family Welfare, it announces the publication of the New Drugs and Clinical Trials Rules, 2019. These rules concern the regulation and standards for new drugs and clinical trials in India.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDI2MQ=="
}
|
|
CDSCO Draft Guidance for CTD Preparation
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTE=
|
CDSCO - New Drugs
2025-12-30T14:53:54.616403
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CDSCO Draft Guidance for CTD Preparation",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cd3/CTD Guidance Final.pdf",
"release_date": "2018-02-09",
"relevancy_score": 80,
"scraped_at": "2025-12-15T05:27:04.627000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance issued by the Central Drugs Standard Control Organization (CDSCO), intended for the industry on preparing the Common Technical Document (CTD) for new drug applications. It aims to standardize the submission format for importing, manufacturing, and marketing approvals of new pharmaceuticals for human use in India, which is aligned with international standards. The document invites feedback from stakeholders within 60 days of publication.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTE="
}
|
|
Withdrawal Order for Olaparib Tablets in Ovarian Cancer
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTEyNjk=
|
CDSCO - New Drugs
2025-12-30T14:53:52.582556
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "order",
"generated_title": "Withdrawal Order for Olaparib Tablets in Ovarian Cancer",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc8/All State-UTs Drugs Controller Olaparib Withdrawal.pdf",
"release_date": "2024-05-16",
"relevancy_score": 100,
"scraped_at": "2025-12-15T05:27:47.856000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document from the Central Drugs Standard Control Organization (CDSCO) announces the withdrawal of the indication for Olaparib Tablets in certain ovarian cancer treatments due to potential detrimental effects on survival. The directive requires manufacturers to withdraw marketing for these specific uses and revise package inserts. The order follows analysis and expert consultation regarding the drug\u0027s efficacy.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTEyNjk="
}
|
|
CDSCO Update on New Drugs FAQs 2020
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTU4OA==
|
CDSCO - New Drugs
2025-12-30T14:53:51.842515
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CDSCO Update on New Drugs FAQs 2020",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cd0/notice18.2.2020faqnew.pdf",
"release_date": "2020-02-18",
"relevancy_score": 90,
"scraped_at": "2025-12-15T05:27:58.225000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document, issued by the Central Drug Standard Control Organization (CDSCO), provides updated FAQs on the New Drugs and Clinical Trial Rules 2019. It clarifies the applicability of these rules for new and investigational drugs, and details the submission process for applications related to manufacturing and study permissions. The updates aim to address concerns raised regarding rule applications for non-new drugs.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTU4OA=="
}
|
|
FAQs Update on New Drugs and Clinical Trials
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc4OQ==
|
CDSCO - New Drugs
2025-12-30T14:53:51.649266
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "FAQs Update on New Drugs and Clinical Trials",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cd1/noticefaqnewdrug.pdf",
"release_date": "2020-02-18",
"relevancy_score": 90,
"scraped_at": "2025-12-15T05:28:17.437000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a notice from the Central Drug Standard Control Organization (CDSCO) concerning updates to FAQs on the New Drugs \u0026 Clinical Trial Rules 2019. It clarifies the applicability of these rules and provides updated guidance on the submission process for manufacturing and testing new drugs and investigational new drugs. Dr. V. G. Somani, Drugs Controller General (India), is associated with this release.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc4OQ=="
}
|
|
CDSCO Public Notices on Drug Applications and Trials
Score: 95 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTYyMg==
|
CDSCO - New Drugs
2025-12-30T14:53:51.050344
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CDSCO Public Notices on Drug Applications and Trials",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cce/NoticesforStreamliningcopp.pdf",
"release_date": "2020-02-21",
"relevancy_score": 95,
"scraped_at": "2025-12-15T05:28:25.754000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document consists of several public notices issued by the Central Drugs Standard Control Organization (CDSCO) under the Directorate General of Health Services, India. The notices address various regulatory concerns such as clarifications on BA/BE study permissions, approval processes for Fixed Dose Combinations, impurity specifications for Investigational New Drugs (INDs), and procedures for pre-submission meetings under the New Drugs and Clinical Trials Rules 2019. These notices inform stakeholders about regulatory procedures and clarifications in drug trials and approvals.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTYyMg=="
}
|
|
Draft Guidance on Clinical Trials and New Drug Approval
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mw==
|
CDSCO - New Drugs
2025-12-30T14:53:48.539820
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Draft Guidance on Clinical Trials and New Drug Approval",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cbf/Guidance_for_New_Drug_Approval-23july2.pdf",
"release_date": "2014-01-04",
"relevancy_score": 80,
"scraped_at": "2025-12-15T11:22:39.930000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance issued by the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health \u0026 Family Welfare, Government of India. It provides guidelines on the approval process for clinical trials and new drugs in India, including different categories of new drugs and the data required for their approval. Comments and suggestions on this draft are invited from the public, with a deadline of August 24, 2011.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mw=="
}
|
|
CDSCO FAQ on Phytopharmaceutical Drug Approval Process
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MA==
|
CDSCO - New Drugs
2025-12-30T14:53:48.065877
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CDSCO FAQ on Phytopharmaceutical Drug Approval Process",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc1/Phyto.pdf",
"release_date": "2014-01-04",
"relevancy_score": 80,
"scraped_at": "2025-12-15T11:22:47.293000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is an FAQ released by the Central Drugs Standard Control Organization (CDSCO) concerning the approval process for new phytopharmaceutical drugs in India. It provides detailed explanations on various aspects, including the definition of these drugs, the clinical trial requirements, application processes, and related fees. The document is aimed at public awareness and guidance for applicants looking to import or manufacture new phytopharmaceutical drugs.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MA=="
}
|
|
New Drug Approval Testing Timelines Announced
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0NA==
|
CDSCO - New Drugs
2025-12-30T14:53:47.897401
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "New Drug Approval Testing Timelines Announced",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cca/Testing of all categories of new drugs for their approval.pdf",
"release_date": "2020-03-13",
"relevancy_score": 90,
"scraped_at": "2025-12-15T11:22:54.586000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This public notice from the Central Drugs Standard Control Organization (CDSCO) informs stakeholders about new timelines for laboratory testing required for the approval of new drugs. The document details different timelines based on drug categories to streamline the approval process under the New Drugs and Clinical Trials Rules, 2019. It addresses concerns regarding current requirements and provides specifics on testing periods for various types of new drugs.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0NA=="
}
|
|
Empagliflozin Tablets Safety Advisory and Updates
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MQ==
|
CDSCO - New Drugs
2025-12-30T14:53:47.461220
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "advisory",
"generated_title": "Empagliflozin Tablets Safety Advisory and Updates",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cbe/Empagliflozin.pdf",
"release_date": "2014-01-04",
"relevancy_score": 90,
"scraped_at": "2025-12-15T11:23:06.797000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document from the Central Drugs Standard Control Organization (CDSCO) addresses the updated package insert for Empagliflozin tablets, reflecting new warnings about potential side effects issued by the US FDA. It specifically discusses risks such as diabetic ketoacidosis and serious urinary tract infections. The Directorate General of Health Services directs all state drug controllers to be informed and take necessary actions.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0MQ=="
}
|
|
Impurity Limit Specifications for Investigational New Drugs
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc5NA==
|
CDSCO - New Drugs
2025-12-30T14:53:45.455217
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Impurity Limit Specifications for Investigational New Drugs",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6ccd/fixingINDs.pdf",
"release_date": "2020-02-21",
"relevancy_score": 80,
"scraped_at": "2025-12-15T11:23:10.163000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "The document is issued by the Drugs Standard Control Organization (CDSCO) under the Government of India, focusing on the subject of setting impurity limits in the specifications of Investigational New Drugs (INDs). It discusses the procedures for processing applications related to clinical trials. As an internal document, it addresses specifics relevant to regulatory affairs in drug control.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc5NA=="
}
|
|
CDSCO Notice on New Drug Permissions Process
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTYyMQ==
|
CDSCO - New Drugs
2025-12-30T14:53:44.988223
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CDSCO Notice on New Drug Permissions Process",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6ccf/NOTICE20feb20.pdf",
"release_date": "2020-02-20",
"relevancy_score": 90,
"scraped_at": "2025-12-15T11:23:30.267000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This is a public notice from the CDSCO regarding the grant of permissions for manufacturing or importing new drugs under the New Drugs and Clinical Trials Rules 2019. It addresses issues concerning the submission and processing of Form CT applications, detailing that these will be processed within seven working days. The notice provides clarity on the procedural guarantees and reorganizes the application process for trial batch approvals.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTYyMQ=="
}
|
|
Establishment of New Drug Advisory Committee Order
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTY=
|
CDSCO - New Drugs
2025-12-30T14:53:44.603038
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "order",
"generated_title": "Establishment of New Drug Advisory Committee Order",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cbc/newdrug_advisory_commitee.pdf",
"release_date": "2018-02-09",
"relevancy_score": 90,
"scraped_at": "2025-12-15T11:24:30.681000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is an official government order issued by the Ministry of Health \u0026 Family Welfare, India, on the constitution of the New Drug Advisory Committee (NDAC). The committee is tasked with advising the Drugs Controller General of India (DCGI) on the review and regulatory approval of new drugs, excluding investigational new drugs, for categories such as reproductive and urology, as well as cardiovascular and renal. The order outlines the terms of reference, committee composition, and operational guidelines for the NDAC.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTY="
}
|
|
Draft Guidance on CMC and Stability Data for New Drugs
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDk=
|
CDSCO - New Drugs
2025-12-30T14:53:44.110069
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Draft Guidance on CMC and Stability Data for New Drugs",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc7/Guidance CMC _ Stability Data.pdf",
"release_date": "2018-02-09",
"relevancy_score": 80,
"scraped_at": "2025-12-15T17:22:10.044000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance prepared by the Central Drugs Standard Control Organization of India outlining the requirements for submitting chemical and pharmaceutical information, including stability study data, for the approval of clinical trials and bioequivalence studies. It is aimed at ensuring the safety and quality of proposed clinical trials by mandating thorough submission of relevant data before approval is granted. This guidance specifically applies to new drug formulations and excludes biologicals and vaccines.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDk="
}
|
|
CDSCO July 2011 Guidance on Clinical Trials Approval
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mw==
|
CDSCO - New Drugs
2025-12-30T14:53:43.988740
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "CDSCO July 2011 Guidance on Clinical Trials Approval",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/6941d025c6178ad47676d43a/Guidance_for_New_Drug_Approval-23july2.pdf",
"release_date": "2014-01-04",
"relevancy_score": 80,
"scraped_at": "2025-12-16T21:36:23.585000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance issued by the Central Drugs Standard Control Organization (CDSCO) for the approval of clinical trials and new drugs in India. It outlines the requirements and procedures for obtaining approval to import or manufacture new drugs for marketing, based on the Drugs and Cosmetics Rules. It is intended for feedback and aims to streamline the application and review process for new drugs, excluding biologicals and vaccines.",
"url": "https://cdsco.gov.in/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mw=="
}
|
|
Draft Guidelines for Reporting Serious Adverse Events
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1MA==
|
CDSCO - New Drugs
2025-12-30T14:36:26.583406
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Draft Guidelines for Reporting Serious Adverse Events",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc0/SAEGUIDELINES552011.pdf",
"release_date": "2014-01-04",
"relevancy_score": 80,
"scraped_at": "2025-12-15T05:24:46.127000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance issued by the Drugs Controller General (India) under the Central Drugs Standard Control Organization (CDSCO) regarding the reporting of serious adverse events (SAEs) occurring in clinical trials. It aims to standardize the format and processes for SAE reporting to ensure uniformity and completeness of data submitted to CDSCO. The document includes definitions, regulatory responsibilities, and specific reporting requirements.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1MA=="
}
|
|
Drugs Approved in India: 2013 Summary List
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Ng==
|
CDSCO - New Drugs
2025-12-30T14:36:26.476098
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Drugs Approved in India: 2013 Summary List",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc3/New2013.pdf",
"release_date": "2013-11-27",
"relevancy_score": 80,
"scraped_at": "2025-12-15T05:24:57.090000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "The document is a comprehensive list issued by a regulatory authority detailing drugs approved between January 1, 2013, and December 31, 2013. Each entry includes the drug name, indication, and date of approval. It acts as a record for clinicians and pharmaceutical stakeholders to reference the approved drugs during that period.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Ng=="
}
|
|
Order for Safety and Efficacy Approval of FDCs
Score: 90 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mg==
|
CDSCO - New Drugs
2025-12-30T14:36:26.194755
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "order",
"generated_title": "Order for Safety and Efficacy Approval of FDCs",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cbd/CircularRegardingApprovalfdcwithoutapprovaldcgi.pdf",
"release_date": "2014-02-03",
"relevancy_score": 90,
"scraped_at": "2025-12-15T05:25:09.078000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document, issued by the Directorate General of Health Services under the Ministry of Health \u0026 Family Welfare, is an official order to all State/UT Drugs Controllers regarding the approval of the safety and efficacy of Fixed Dose Combinations (FDCs) permitted for sale without prior approval from the DCGI. It directs manufacturers to submit necessary documents and applications to CDSCO for evaluation by expert committees to regularize these FDCs. The document emphasizes the need for timely compliance with the directive.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0Mg=="
}
|
|
Establishment of New Drug Advisory Committee Order
Score: 100 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1Mg==
|
CDSCO - New Drugs
2025-12-30T14:36:26.103963
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "order",
"generated_title": "Establishment of New Drug Advisory Committee Order",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc2/newdrug_advisory_commitee.pdf",
"release_date": "2014-01-04",
"relevancy_score": 100,
"scraped_at": "2025-12-15T05:26:28.920000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is an official order issued by the Ministry of Health \u0026 Family Welfare, Government of India, dated March 31, 2011, concerning the constitution of a New Drug Advisory Committee (NDAC). The committee will advise the Drugs Controller General of India (DCG(I)) on matters related to the review of applications, approval of new drugs, and clinical trials. The order outlines the committee\u0027s composition, terms of reference, and operational guidelines, emphasizing the assessment of new drugs\u0027 risks, innovation, and necessity in India.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1Mg=="
}
|
|
Guidelines for Approval of Synthetic Drugs 2023
Score: 95 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0MQ==
|
CDSCO - New Drugs
2025-12-30T14:36:25.815358
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "Guidelines for Approval of Synthetic Drugs 2023",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc9/Guidelines for approval of synthetically manufactured drug which has been previously approved as r-DNA derived drug..pdf",
"release_date": "2020-03-13",
"relevancy_score": 95,
"scraped_at": "2025-12-15T05:26:56.679000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document issued by the CDSCO outlines guidelines for the approval of synthetically manufactured drugs that were previously approved as r-DNA derived drugs. It specifies that applications for such drugs must consider safety and efficacy according to the New Drugs and Clinical Trials Rules, 2019, and mentions the treatment of first-time synthetically manufactured peptides. The notice is signed by Dr. V.G. Somani, the Drugs Controller General of India.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0MQ=="
}
|
|
CMC Document Requirements for New Drug Indications
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mg==
|
CDSCO - New Drugs
2025-12-30T14:36:25.669158
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "public_notice",
"generated_title": "CMC Document Requirements for New Drug Indications",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6ccc/Requirement of CMC documents for approval of additional indication of an already drug product.pdf",
"release_date": "2020-03-13",
"relevancy_score": 80,
"scraped_at": "2025-12-15T05:26:57.245000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is an official notice issued by the Central Drugs Standard Control Organization (CDSCO) under the Government of India. It outlines the requirements for CMC documents necessary for the approval of additional indications for an already approved drug product, according to the New Drugs and Clinical Trials Rules, 2019. Specifically, it addresses requirements for importing or manufacturing drugs that are already approved and marketed in India with new claims.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc0Mg=="
}
|
|
Draft Guidance on Chemical Information for Clinical Trials
Score: 80 · Relevant: Yes
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OQ==
|
CDSCO - New Drugs
2025-12-30T14:36:25.592345
|
HTTP 400 |
HTTP 400
Raw responseInvalid SeedUrl |
{
"classified_type": "document",
"generated_title": "Draft Guidance on Chemical Information for Clinical Trials",
"is_relevant": true,
"local_file_path": "https://crawler-testing.pranapr.com/files/downloads/693f9a439227e31ef2cf6cc5/GuidanceCMCStabilityData.pdf",
"release_date": "2012-07-27",
"relevancy_score": 80,
"scraped_at": "2025-12-15T05:26:57.275000Z",
"seed_url": "https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/",
"summary": "This document is a draft guidance issued by the Central Drugs Standard Control Organization (CDSCO) concerning the necessary chemical and pharmaceutical information, including stability study data, required for the approval of clinical trials and bioequivalence studies in India. It outlines regulatory requirements based on the Drugs and Cosmetics Rules, providing detailed guidelines to ensure drug safety and quality before approval for clinical investigations. The guidance is intended for feedback and comments within a specified period.",
"url": "https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI0OQ=="
}
|